Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1939  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1118    
    Printed38    
    Emailed0    
    PDF Downloaded16    
    Comments [Add]    

Recommend this journal

 

 BRIEF REPORT
Year : 2021  |  Volume : 69  |  Issue : 6  |  Page : 1781--1784

Effect of Low-Dose Naltrexone on Egyptian Children with Intractable Epilepsy: A Case Series Study


1 Department of Neurology, Cairo University, Giza, Egypt
2 Department of Clinical Neurophysiology, Cairo University, Giza, Egypt

Correspondence Address:
Dr. Nesma Mounir
Department of Neurology and Clinical Neurophysiology, Cairo University, Kasr Al-Aini Hospital, Al-Manyal Street, Garden City, Cairo 11562
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.333523

Rights and Permissions

Epilepsy is a chronic neurological disorder affecting 50 million patients worldwide, in need of continuous treatment, while 30% of them are refractory to treatment. Despite multiple antiepileptic drugs are available for the treatment of epilepsy, still refractory epilepsy especially in children represents a social burden in developing countries. Low-dose naltrexone (LDN) has been proposed as an immune modulator in multiple diseases and proved benefit especially in diseases with immune dysregulation. The purpose of this study is to demonstrate the effect of LDN in the treatment of children with intractable epilepsy and discuss its potential role in epileptogenesis process.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow